Tuberculosis y sida 15 años después (1981-1996): Nuevas perspectivas

Medicina Clinica

Volumn 111, Issue 16, 1998, Pages 628-634

  De March Ayuela, Pedro ^a   García González, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; HUMAN; REVIEW; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; HUMANS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0032517457     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. De March Ayuela P. La tuberculosis en España. Tribuna Médica 1988; 23: 3-4.
2. De March Ayuela P. ¿Dónde tratar a nuestros tuberculosos? [editorial]. Arch Bronconeumol 1989; 25: 249-251.
3. De March Ayuela P. Tuberculosis y sida. Situación en España. Perspectives [editorial]. Rev Clin Esp 1990; 186: 365-368.
4. National Research Council. The social impact of AIDS in the United States, Washington, DC: National Academy Press, 1993.
5. De March Ayuela P, Garcia González A. La evolución de la infección VIH/sida en los países desarrollados. Impacto sobre la tuberculosis. Med Clin (Barc) 1993; 100: 187-193.
6. CDC. HIV prevalence stimates and AIDS case projections for the United States: report based upon a workshop. Morb Mortal Wkly Rep 1990; 39: RR-16.
7. CDC. Projections of the number of persons diagnosed with AIDS and the number of immunosuppressed HIV/infected persons-United States. Morb Mortal Wkly Rep 1992; 41: RR-18.
8. CDC. First 500,000 AIDS cases-United States, 1995. Morb Morta Wkly Rep 1995; 44: 849-853.
9. HIV/AIDS Surveillance Report. US Department of Health and Human Services, 1997; 9: 1.
10. Villar Álvarez F, Bolca Laguarta A, Rodríguez Artalejo F, Medrano Albero MJ, Tello Anchuela O, Garcia Caballero J, El sida en España; predicción de nuevos casos mediante el uso de modelos matemáticos. Rev Clin Esp 1988; 183: 60-63.
11. Fernández Sierra MA, Gómez Olmedo M, Delgado Rodríguez M, Gálvez Vargas R. Infección por el virus de la inmunodeficiencia humana en la población española, II: metaanálisis de las tendencias temporales y geográficas. Med Clin (Barc) 1990; 95: 366-371
12. Gandarillas Grande A, Medrano Albero MJ, Tello Anchuela O. Tendencias y predicciones del sida en España. Rev Sanid Hig Publ 1991; 65: 87-88.
13. Castilla Catalán J, Gutiérrez Rodriguez A, Tello Anchuela O. Changes in AIDS incidence trends in Spain. AIDS 1994; 8: 1.163-1.167.
14. Caylà JA, Jansà JM, Iglesias B, Artazcoz L, Plasencia A. Epidemiologia del sindrome de immunodeficiencia adquirida en Barcelona (1981-1991). Estudio descriptivo y de tendencias temporales. Med Clin (Barc) 1993; 101: 286-293.
15. CDC. Update: trends in AIDS incidence-United States. 1996. Morb Mortal Wkly Rep 1997; 46: 861-867.
16. European Centre for the Epidemiology Monitoring of AIDS. Saint-Maurice, HIV/AIDS surveillance in Europe, 1997; 5.
17. Instituto de Salud Carlos III. Centro Nacional de Epidemiología. Registro Nacional de Sida. Situación a 30 de junio de 1997 Madrid: Ministerio de Sanidad y Consumo, 1997.
18. Brookmeyer R. Reconstruction and future trends of the AIDS in the United States. Science 1991; 253: 37-42.
19. Coolfont Report. A PHS plan for prevention and control of AIDS and the AIDS virus. Public Health Rep 1986; 101: 341-348.
20. CDC. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop, October 31-November 1, 1989. Morb Mortal Wkly Rep 1990; 39: 110-112, 117-119.
21. Karon JM, Rosenberg PhS, McQuillan G, Khore M, Gwinn M, Petersen LR. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA 1996; 276: 126-131.
22. Rosenberg PhS. Scope of the AIDS epidemic in the United States. Science 1995; 270: 1.372-1.375.
23. Vigilancia globalizada de la infección por el VIH er la Comunidad de Madrid. Bol Epidemiol 1997; 7: 20-21.
24. AIDS and HIV infection in the United Kingdom: montly report. Com Dis Rep 1997; 7: 397-408.
25. CDC. Recomendation for prevening transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure prone invasive procedures. Morb Mortal Wkly Rep 1991; 40: RR-8.
26. Gerberling JL, Hopewell PC, Kaminsky LS, Sande MA. Transmission of hepatitis B without transmission of AIDS by accidental needlesting. N Engl J Med 1985; 312: 56-57.
27. Pérez Trallero E, Cilla G, Alcorta M, Elósegui ME, Sáenz Dominguez JR. Occupational transmission of HCV. Lancet 1994; 344: 548.
28. Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the adquired immunodeficiency syndrome. N Engl J Med 1985; 313: 266.
29. Kramer F, Sasse SA, Simms JC, Lledom JM. Primary cutaneous tuberculosis after a needlestick injury from a patient with AIDS and undiagnosed tuberculosis. Ann Intern Med 1993; 119: 594-595
30. Uribe-Salas F, Hernández-Ávila M, Code-González CJ, Juárez-Figueroa L, Allen B, Anaya-Ocampo R et al. Low prevalence of HIV infection and sexually transmitted disease among female commercial sex workers in Mexico City. Am J Publ Health 1997; 87: 1.012-1.015.
31. Royce RA, Seña A, Cates W, Cohen M. Sexual transmission of HIV. N Engl J Med 1997; 336: 1.072-1.076.
32. European Study Group of Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. Br Med J 1992; 304: 809-813.
33. Zunzünegui V, Casabona J, Laguna J, Tor J, Ortiz C, Alameda J et al. Factores de resgo para la transmision heterosexual del HIV de varón a mujer en un estudio multicéntrico español. Med Clin (Barc) 1992; 98: 721-725.
34. European Study Group. European Community concerted action of HIV seroprevalence among sexually transmitted disease patients on 18 European sentinel networks. AIDS 1993; 7: 393-400.
35. Brody S. Lack of evidence for transmission of human immunodeficiency virus through vaginal intercourse. Arch Sexual Behavior 1995; 24: 383-391.
36. Pérez-Stable EJ. Cuba's response to the HIV epidemic. J Public Health 1991; 81: 563-567.
37. Guimaraes MDC, Muñoz A, Broschi-Pinto C, Castillo EA, Rio de Janeiro Heterosexual Study Group. HIV Infection among female partners of seropositive men in Brazil. Am J Epidemiol 1995; 142: 538-547.
38. Seidlin M, Vogler M, Lee E, Shyong Lee Y, Dublin N. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS 1993; 7: 1.247-1.254.
39. Johnson AM. Heterosexual spread of HIV infection. Br Med J 1992; 305: 179-180.
40. Deschamps MH, Pape JW, Hafner A, Johnson WD. Heterosexual transmission of HIV in Haiti. Ann Intern Med 1996; 125: 324-330
41. European Working Group on HIV Infection in female prostitutes. HIV infection in European female sex workers: epidemiological link with use of petroleum-based lubricants. AIDS 1993; 7: 401-408
42. Estébanez F, Fitch K, Nájera R. HIV and female sex workers. Bull World Health Organ 1993; 71: 397-412.
43. McKeganey NP. Prostitution and HIV. What do we know and where might research be targeted in the future? AIDS 1994; 8: 1.215-1.226.
44. Ward H, Day S, Mezzone J, Dunlop L, Donegan C, Farrar S et al. Prostitution and risk of HIV: female prostitutes in London. Br Med J 1993; 307: 356-358.
45. Stewart GT. Errors in predictions of the incidence and distribution of AIDS. Lancet 1993; 341: 898.
46. Heterosexual AIDS: pessimism pandemics, and plain hard facts [editorial]. Lancet 1993; 341: 863-864.
47. Padian NS, Shibosky SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in Northern California: results from a ten year study. Am J Epidemiol 1997; 146: 350-357.
48. Padian NS, Shiborsky SC, Jewel NT. Female-to-male transmission of human immunodeficiency virus. JAMA 1991; 266: 1.664-1.667.
49. Radian NS, Shiborsky SC, Jewel NT. Heterosexual transmission of HIV. JAMA 1992; 267: 1.917-1.918.
50. Nájera Morrondo R. Nuevos datos y reflexiones sobre la transmision heterosexual [editorial]. Pub Seisida 1992; 3: 239-243.
51. Cabases Hita JM. ¿Cuánto nos cuesta el sida? [editorial]. Med Clin (Barc) 1995; 104: 173-175.
52. Guimbao Bescos J, Vergara Ugarriza A. ¿Aumenta o disminuye el sida? Med Clin (Barc) 1993; 101: 678.
53. Chin J, Lwanga SK. Estimation and projection of adult AIDS cases: a simple epidemiological model. Bull World Health Organ 1991; 69: 399-406.
54. Mertens TE, Low-Beer D. HIV and AIDS: where is the epidemic going? Bull World Health Organ 1996; 74: 121-129.
55. CDC. Tuberculosis, final data. United States-1986. Morb Mortal Wkly Rep 1988; 36: 817-820.
56. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE. Tuberculosis in the United States. JAMA 1989; 262: 385-389.
57. Snider DE, Roper WL. The new tuberculosis. N Engl J Med 1992; 325: 703-705.
58. Cantwell MF, Snider DE, Cauthen GM, Onorato JM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272; 535-539.
59. CDC. Tuberculosis morbility-United States 1995. Morb Mortal Wkly Rep 1996; 45: 365-370.
60. CDC. Tuberculosis morbility-United States 1996. Morb Mortal Wkly Rep 1997; 46: 695-700.
61. CDC. Tuberculosis morbility-United States 1997. Morb Mortal Wkly Rep 1998; 47: 253-258.
62. The American Lung Association Conference on Re-establishing Control of tuberculosis in the United States. Am J Respir Crit Care Med 1996; 154: 251-262.
63. Davies PDO. The recent arrest in the decline of the notification in England and Wales is probably not related to HIV infection. Am Rev Respir Dis 1988; 137 (Supl 2): 257.
64. Davies PDC. Tuberculosis and HIV: blind man's buff [editorial]. Thorax 1993; 48: 193-194.
65. Watson JM, Gill ON. TB and infection surveillance in England and Wales. Thorax 1988; 43: 855 P.
66. Watson JM, Meredith SK, Whitmore-Overton E, Bannister B, Darbyshire JM. Tuberculosis and HIV: estimates of the overlap in England and Wales. Thorax 1993; 48: 199-203.
67. Rieder HL. Infección por VIH en EE.UU. y en Europa. Bull Int Union Tuberc 1990; 65: 94.
68. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in the Western Europe. Bull World Health Organ 1993; 71: 297-306.
69. Styblo K. The potential impact of AIDS on the tuberculosis situation in developed and developing countries. Bull Int Union Tuberc 1988; 63: 25-28.
70. Styblo K. Erradicación de la tuberculosis en los paises desarrollados en la era del virus de la inmunodeficiencia humana. Bull Int Union Tubers Lung Dis 1989; 64: 60-67.
71. Stybio K. Aspectos sobre la tuberculosis y la infeccion VIH a nivel mundial. Bull Int Union Tuberc Lung Dis 1990; 65: 30-35.
72. Blom BR, Murray ChJL. Tuberculosis: Commentary on a reemergent killer. Science 1992; 257: 1.055-1.161.
73. De March Ayuela P. Situación actual de la tuberculosis en España Med Clin (Barc) 1991; 97: 463-472.
74. Standaert B, Niragira F, Kadende P, Piot P. The association of tuberculosis and HIV infection in Burundi. AIDS Res Hum Retroviruses 1989; 5: 247-251.
75. Cayla JA, Garcia de Olalla P, Galdós-Tangüis H, Vidal R, Lópoz-Colomés JL, Gatell JM et al. The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS 1996; 10: 95-100.
76. Pitchenik AE, Burr J, Suárez M, Fertel D, González G, Moas C. Human T-cell lynphotropic virus III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study. Am Rev Respir Dis 1987; 185: 875-879
77. Manoff SB, Cauthen G, Stonenburger R, Bloch A, Schultz S, Snider D et al. TB patients with AIDS are they more likely to spread TB? Estocolmo: IV Intern Conference on AIDS, 1988.
78. Helbert MR, Robinson DS, Buchanan DR, Brown I, Cann K, Pintching AJ et al. Mycobacterial infection in HIV infected patients. Thorax 1988; 43: 849.
79. Klein NC, Duncanson FP, Lenox TH, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonar tuberculosis in AIDS/ARC patients. Chest 1989; 95: 1.190-1.192.
80. Long R, Scaicini M, Mamfreda J, Carré G, Philippe E, Hedrsfield E et al. Impact of HIV type 1 in tuberculosis in rural Haiti. Am Rev Respir Dis 1991; 143: 69-73.
81. Nunn P, Gicheha C, Hayes R, Gathua S, Brindle R, Kibuga D et al. Cross-sectional survey of HIV infection patients with tuberculosis in Nairobi, Kenya. Tuberc Lung Dis 1992; 73: 45-51.
82. Elliot AM, Hayes RJ, Halwiindi B, Luo N, Tembo G, Pobee JOM et al. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS 1993; 7: 981-987.
83. Klausner JD, Ryder RW, Baende E, Lelo V, Williame JC, Ngambolt K et al. Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1-seropositive patients with active pulmonary tuberculosis in Kinshasa. Zaire. J Infect Dis 1993; 168: 106-111.
84. Brindle RJ, Nunn PP, Githui W, Allen BW, Gathua S, Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-961.
85. Smith RL, Yew K, Berkowitz KA, Aranda CP. Factors affecting the yield of acid-fats sputum smears in patients with HIV and tuberculosis. Chest 1994; 106: 684-686.
86. Nunn P, Mungai M, Nyambaya I, Gichena C, Bridle RJ, Dunn DT et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis 1994; 75: 25-32.
87. Pozniak AL, McLeod GA, Ndlovu D, Ross E, Mahari M, Weinberg J. Clinical and chest radiographic features of the associated with human immunodeficiency virus. Am J Respir Crit Care Med 1995; 152: 1.558-1.561.
88. Grupo de Trabajo de Tuberculosis de Neumosur. Caracteristicas epidemiológicas de la enfermedad tuberculose en el ámbito de la Sociedad de Neumólogos del Sur (Neumosur). Neumosur 1995; 7: 115-127.
89. Mbulo G, Godfey-Faussett P. Tuberculin reactivity in housold contacts of HIV positive and negative smear positive tuberculosis cases and control households. Tuberc Lung Dis 1996; 77 (Supl 2): 90.
90. Cauthen GM, Dooley SW, Onorato IM, Ihle WW, Burr JM, Bigler WJ et al. Transmission of Mycobacterium tuberculosis from patients with HIV or AIDS. Am J Epidemiol 1996; 144: 69-77.
91. Olona M, Campins M, Oltra C, Vaqué J. Prevalencia de la infección tuberculosa en personal sanitario. Rev Clin Esp 1989; 185: 44-45.
92. Puyuelo Lanao T, Hernández Martinez E, Gatell Artigas JM, Soriano Marin E, Agusti Vidal A. Prevalencia de la infección tuberculosa en personal sanitario. Med Clin (Barc) 1989; 92: 564-566.
93. Alonso Gutiérrez D, Gutiérrez Alonso JL. Infección tuberculosa en personal sanitario. Med Clin (Barc) 1992; 98: 318.
94. De March Ayuela P. Anotaciones sobre la oportunidad de suprimir la vacunacion BCG en España. Rev Clin Esp 1988; 183: 442-443.
95. De March Ayuela P. El declive de la infección tuberculosa en los escolares de Barcelona. Med Clin (Barc) 1989; 92: 718.
96. De March Ayuela P. Aspectos epidemiológicos de la tuberculosis. Rev Esp Microbiol Clin 1989; 4: 460.
97. De March Ayuela P. Epidemiologia de la tuberculosis en Cataluña, Med Clin (Barc) 1991; 97: 356.
98. De March Ayuela P. Informe: la tuberculosis en Cataluña, Generalitat de Catalunya, 1983.
99. Villalbi JR, Caylá JA, Taberner JL, Serra T. El declive de la infección tuberculosa en los escolares de Barcelona. Med Clin (Barc) 1988; 91: 371-374.
100. Alcaide Mejias J, Altet Gómez MN, Taberner Zaragoza JL, Garrido Morales P, Salleras Sanmarti L. Epidemiologia de la tuberculosis en Cataluña, 1982-1989. Med Clin (Barc) 1990; 95: 529-534.
101. Villalbi JR, Caylà JA, Iglesias B, Ferrer A, Casañas P. The evolution of tuberculosis infection among schoolchildren in Barcelona and HIV epidemic. Tuberc Lung Dis 1994; 75: 105-109.
102. Vall Mayans M, Maguire A, Miret M, Alcaide J, Parrón I, Casabona J. The spread of AIDS and the re-emergency of tuberculosis in Catalonia. Spain. AIDS 1997; 11: 499-505.
103. Alcaide J, Altet MN, Batalla J, Plans P, Taberner JL, Salleras L et al. Estudio comparativo de la sensibilidad cutanea humana a 2 y 5 unidades internacionales de la tuberculina PPD RT-23 con Tween 80. Med Clin (Barc) 1992; 99: 525-528.
104. Chaparras SD, Mac Vandiviere H, Melvin I, Koch G, Beeker C. Tuberculin test: variability with tuberculosis Mantoux procedure. Am Rev Respir Dis 1985; 132: 175-177.
105. Styblo K, Meijer J, Sutherland I. La transmision du bacille tuberculeux Son évolution au sein d'une collectivité humaine. Bull World Health Organ 1969; 41: 137-178.
106. Sutherland I, Styblo K, Sampalik M, Bleiker MA. Annual risks of tuberculosis infection in 14 countries derived from the results of tuberculin surveys in 1948-1952. Selected Papers 1971; 14: 75-113.
107. De March Ayuela P. Micobacterias no tuberculosas en Barcelona, I: sensibilizaciones comparativas entre tuberculina RT-23 con sensitina del Mycobacterium avium y scrofulaceum. Rev Clin Esp 1984; 175: 141-147.
108. De March Ayuela P, Bleiker MA. Skin sensitivity to human PPD and to PPD-scrophulaceum in schoolchildren in Barcelona. Spain. 1983. Intern Tuberculosis Surveillance Centre Report to the Commission of the European Communities and to the Directing Committee of ITCS Barcelona: The Hague.
109. Bleiker MA, Misljenovic O, Styolo K. Is non-specific tuberculin sensitibity making progress in Europe? Bull Int Union Ag Tuberc 1984; 59: 123-125.
110. Ordobás Gavin M. Encuesta de tuberculina en la Comunidad de Madrid. Curso 1993-94. Dirección General de Prevencion y Promoción de la Salud. Documentos Técnicos de Salud Pública, no. 28. Consejeria de Sanidad y Servicios Sociales, 1995.
111. CDC. National action plan to combat multidrug-resistant tuberculosis. Morb Mortal Wkly Rep 1992; 41: RR-5-47.
112. CDC. Management of persons exposed to multidrug-resistant tuberculosis. Morb Mortal Wkly Rep 1992; 41: RR-61-71.
113. Bloch AB, Cauthen GM, Onorato IM, Dansbury KG, Kelly GD, Driver CR et al. Natiowide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
114. De March Ayuela P. La transmision de la resistencia a Mycobacterium tuberculosis en los infectados por e: VIH. La llamada tercera epidemia del VIH [editorial]. Med Clin (Barc) 1994; 102: 98-100.
115. Nolan CM. Multidrug-resistant tuberculosis in the USA: the end of the beginning [editorial]. Tuberc Lung Dis 1996; 77: 293-294.
116. CDC. The role of BCG in the prevention and control of tuberculosis in the United States. Morb Mortal Wkly Rep 1996; 45: 1-9.
117. De March Ayuela P. Tuberculosis La enfermedad que no se despidió y tampoco resurge. Jano 1996; 51: 73-78.
118. Moore M, Onorato I, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the United States. 1993-1996. JAMA 1997; 278: 833-837.
119. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML et al. Original and intestate spread of a New York City multidrug-resistance Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-457.
120. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. Epidemiology and clinical outcomes. JAMA 1996; 276: 1.229-1.235.
121. Bloch AB, Simony PH, McCray E, Castro KG. Preventive multidrug-resistant tuberculosis [editorial]. JAMA 1996; 275: 487-489.
122. Nardell EA, Brickner PhW. Tuberculosis in New York City. Focal transmission of an often fatal disease [editorial]. JAMA 1996; 276: 1.259-1.260.
123. Grupo de Estudio de Tuberculosis Resistente en Madrid: Coordinadores: Peña JM, Ortega A. Estudio transversal multihospitalario de Tuberculosis y resistencia en Madrid (octubre de 1993, abril de 1994). Med Clin (Barc) 1996; 106: 1-6.
124. Herrera D, Cano R, Godoy P, Peiró EF, Castell JI, Ibáñez C et al. Multidrug-resistant tuberculosis outbreak on an HIV ward. Madrid. Spain 1991-1995. Morb Mortal Wkly Rep 1996; 45: 330-333.
125. De March Ayuela P. La tuberculosis resistente en Madrid. La coenfermedad de tuberculosis y sida. Med Clin (Barc) 1996; 107: 357-358.
126. Drobniewsky F. Is death inevitable with multiresistant TB plus HIV infection? Lancet 1997; 349: 71-72.
127. Visikum K, Kok-Jensen A. Multidrug-resistant tuberculosis in Denmark 1993-1995. Int J Tuberc Lung Dis 1997; 1: 299-301.
128. Turett GS, Telzak EE, Torian LV, Blum S, Alland D, Weisfuse I et al. Improved outcomes for patient with multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1.238-1.244.
129. De March Ayuela P. Situación actual de la tuberculosis en España [editorial]. FMC 1996; 3: 483-485.
130. Rey P, Ausina V, Casal M, Cayla JA, De March Ayuela P, Moreno S et al. Situacion actual de la tuberculosis en España. Una perspectiva sanitaria en precario respecto a los paises desarroilados. Med Clin (Barc) 1995; 105: 703-707.
131. Galdós Tangüis H, Gaylá JA, Jamsá JM, Garcia de Olalla P, Brugal MT, Cortes PJ. La tuberculosis en Barcelona. Informe 1996. Barcelona: Institut Municipal de Salut Pública, Ajuntament de Barcelona, 1997.
132. Miret-Cuadras P, González-Fernández P, López-Sanmartin JL, Pina Gutiérrez JM. Programa de la tuberculosi, Regió Sanitaria Centre. Memória 1996. Barcelona: Institut Catalá de la Salut, 1997.